デフォルト表紙
市場調査レポート
商品コード
1707001

構造心臓デバイスの世界市場レポート 2025年

Structural Heart Devices Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
構造心臓デバイスの世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

構造心臓デバイス市場規模は、今後数年間で力強い成長が見込まれます。2029年には複合年間成長率(CAGR)9.6%で164億8,000万米ドルに成長します。予測期間の成長は、高齢化人口の増加、心臓の健康に対する意識の高まり、スクリーニングプログラムの実施、心臓の構造的処置に対する有利な償還政策、新しい構造心臓デバイスに対する規制当局のタイムリーな承認などに起因すると考えられます。予測期間における主な動向としては、経カテーテル弁置換術の採用拡大、先進素材を用いた革新的デバイスの継続的開発、個別化治療アプローチの重視の高まり、ハイブリッド手技の採用拡大、遠隔モニタリングと遠隔医療ソリューションの統合などが挙げられます。

心血管疾患の有病率の増加は、今後数年間における心臓構造機器市場の成長を促進すると予想されます。心血管疾患(CVD)には、冠動脈疾患、心臓発作、脳卒中など、心臓や血管に影響を及ぼすさまざまな疾患が含まれます。心臓病や脳卒中を含む心血管疾患の世界の罹患率は、座りがちなライフスタイル、食生活の乱れ、肥満、喫煙、高齢化などの要因によって着実に上昇しています。構造心臓デバイスは、損傷した心臓弁の修復や交換、構造的欠陥の修正、心臓機能や患者の予後の向上など、これらの疾患の治療に使用されます。例えば、2024年9月、英国を拠点とする心臓血管研究の慈善団体である英国心臓財団(British Heart Foundation)は、英国では約760万人が心臓・循環器系疾患に罹患しており、男性400万人、女性360万人がこれらの疾患を抱えていると報告しました。これらの疾患は英国における全死亡の約27%を占め、年間17万人以上、1日当たり約480人が死亡しており、これは3分に1人が死亡していることに相当します。その結果、心血管疾患の有病率の増加が心臓構造機器市場の拡大に拍車をかけています。

構造心臓デバイス市場の主要企業は、患者の予後を改善し、回復期間を短縮し、構造的な心臓疾患の治療選択肢を広げるために、低侵襲治療技術や機器の開発に注力しています。その顕著な例が自己拡張型経カテーテル大動脈弁移植(TAVI)システムであり、バルーンを膨らませる必要なく、本来の大動脈弁の解剖学的構造内に置換弁を展開・固定するように設計されています。例えば、アボット・ラボラトリーズは2022年12月、最新世代の経カテーテル大動脈弁植え込み(TAVI)システムであるナビトールをインドで発表しました。Navitorは、手術リスクが高いか極めて高い重症の大動脈弁狭窄症患者向けに特別に調整され、弁の漏れを防ぐ独自の設計などの先進技術が組み込まれています。この技術革新により、アボット社の心臓構造用トランスカテーテル・ポートフォリオは拡大し、医師と患者の双方に心臓疾患に対する低侵襲治療の選択肢を提供することになります。Navitorは、冠動脈疾患(CAD)に対する将来的なインターベンションのために、冠動脈へのアクセスを改善することを容易にする環内リーフレットと大きなフレームセルを備えた唯一の自己拡張型TAVIシステムとして際立っています。さらに、この新しいデザインは血行動態を改善し、血流を最適化します。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界構造心臓デバイス PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界の構造心臓デバイス市場:成長率分析
  • 世界の構造心臓デバイス市場の実績:規模と成長, 2019-2024
  • 世界の構造心臓デバイス市場の予測:規模と成長, 2024-2029, 2034F
  • 世界構造心臓デバイス総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界の構造心臓デバイス市場:タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心臓弁デバイス
  • 環状形成リング
  • 閉塞者
  • 配送システム
  • 世界の構造心臓デバイス市場手順別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 交換手順
  • 修理手順
  • 世界の構造心臓デバイス市場:適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心房中隔欠損症
  • 卵円孔開存症
  • 心室中隔欠損症
  • 大動脈弁狭窄症
  • その他の適応症
  • 世界の構造心臓デバイス市場:年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 小児科
  • 大人
  • 世界の構造心臓デバイス市場心臓弁デバイスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 経カテーテル心臓弁
  • 外科用心臓弁
  • 環状形成リング
  • 世界の構造心臓デバイス市場、タイプ別環状形成リングのサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 僧帽弁形成リング
  • 大動脈弁輪形成リング
  • 世界の構造心臓デバイス市場、閉塞物のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 心房中隔欠損(ASD)閉塞器具
  • 卵円孔開存(PFO)閉塞器具
  • 世界の構造心臓デバイス市場、配信システムのタイプ別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • バルーンデリバリーシステム
  • カテーテルベースのデリバリーシステム

第7章 地域別・国別分析

  • 世界の構造心臓デバイス市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界の構造心臓デバイス市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 構造心臓デバイス市場:競合情勢
  • 構造心臓デバイス市場:企業プロファイル
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • W. L. Gore & Associates Inc.
  • Bracco Group
  • LivaNova PLC
  • Meril Life Sciences Pvt. Ltd.
  • CryoLife Inc.
  • Braile Biomedica
  • TTK Healthcare Limited
  • Direct Flow Medical Inc.
  • JenaValve Technology Inc.
  • Micro Interventional Devices Inc.
  • CardioKinetix Inc.
  • Xeltis AG
  • Ancora Heart Inc.
  • JOMDD Inc.
  • Valcare Medical

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 構造心臓デバイス市場2029:新たな機会を提供する国
  • 構造心臓デバイス市場2029:新たな機会を提供するセグメント
  • 構造心臓デバイス市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r31325

Structural heart devices are specialized medical implants or tools tailored for treating various structural defects or abnormalities affecting the heart. They are utilized to repair or replace damaged heart structures, such as valves or septa, thereby restoring normal heart functions and enhancing patient outcomes.

The primary types of structural heart devices include heart valve devices, annuloplasty rings, occluders, and delivery systems. Heart valve devices are medical tools crafted to repair or replace damaged heart valves, ensuring proper blood flow through the heart. These procedures encompass replacement procedures, repair procedures for indications such as atrial septal defect, patent foramen ovale, ventricular septal defect, aortic valve stenosis, and others, catering to age group categories including pediatrics and adults.

The structural heart devices market research report is one of a series of new reports from The Business Research Company that provides structural heart devices market statistics, including structural heart devices industry global market size, regional shares, competitors with a structural heart devices market share, detailed structural heart devices market segments, market trends and opportunities, and any further data you may need to thrive in the structural heart devices industry. This structural heart devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The structural heart devices market size has grown strongly in recent years. It will grow from $10.41 billion in 2024 to $11.44 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%. The growth in the historic period can be attributed to the shift towards less invasive surgical techniques, the demand for minimally invasive structural heart devices, ongoing training and education programs for healthcare professionals, rising healthcare expenditure, growing patient preference for non-surgical or minimally invasive treatment options.

The structural heart devices market size is expected to see strong growth in the next few years. It will grow to $16.48 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to the increasing aging population, growing awareness about heart health, the implementation of screening programs, favorable reimbursement policies for structural heart procedures, timely regulatory approvals for new structural heart devices. Major trends in the forecast period include increasing adoption of transcatheter valve replacement, ongoing development of innovative devices with advanced materials, growing emphasis on personalized treatment approaches, increasing adoption of hybrid procedures, integration of remote monitoring and telehealth solutions.

The increasing prevalence of cardiovascular diseases is expected to drive the growth of the structural heart device market in the coming years. Cardiovascular diseases (CVDs) encompass a range of conditions that affect the heart and blood vessels, such as coronary artery disease, heart attacks, and strokes. The global incidence of cardiovascular diseases, including heart disease and stroke, has been steadily rising, driven by factors such as sedentary lifestyles, poor diet, obesity, smoking, and aging populations. Structural heart devices are used to treat these diseases by repairing or replacing damaged heart valves, correcting structural defects, and enhancing heart function and patient outcomes. For example, in September 2024, the British Heart Foundation, a UK-based cardiovascular research charity, reported that approximately 7.6 million people in the UK are affected by heart and circulatory diseases, with 4 million males and 3.6 million females living with these conditions. These diseases account for about 27% of all deaths in the UK, resulting in over 170,000 deaths annually, or roughly 480 deaths per day, which equates to one death every three minutes. As a result, the growing prevalence of cardiovascular diseases is fueling the expansion of the structural heart device market.

Leading companies in the structural heart devices market are focusing on developing minimally invasive treatment techniques and devices to improve patient outcomes, shorten recovery periods, and broaden treatment options for structural heart conditions. A notable example is the self-expanding transcatheter aortic valve implantation (TAVI) system, designed to deploy and secure the replacement valve within the native aortic valve anatomy without the need for balloon inflation. For instance, in December 2022, Abbott Laboratories introduced Navitor, the latest-generation transcatheter aortic valve implantation (TAVI) system, in India. Navitor is specifically tailored for individuals with severe aortic stenosis at high or extreme surgical risk and incorporates advancements such as a unique design to prevent valve leakage. This innovation expands Abbott's structural heart transcatheter portfolio, offering both physicians and patients minimally invasive treatment alternatives for heart diseases. Navitor stands out as the sole self-expanding TAVI system with intra-annular leaflets and large frame cells, facilitating improved access to coronary arteries for potential future interventions in coronary artery disease (CAD). Additionally, this new design enhances hemodynamics, optimizing blood flow.

In February 2022, Genesis MedTech Group completed the acquisition of JC Medical (JCM) for an undisclosed sum. This strategic move allows Genesis to augment its product portfolio by including J-Valve, a minimally invasive transcatheter aortic valve replacement (TAVR) device designed for both aortic regurgitation and stenosis patients. JC Medical (JCM) is a US-based company specializing in the manufacture of structural heart devices.

Major companies operating in the structural heart devices market are Abbott Laboratories, Medtronic Plc, Boston Scientific Corporation, Terumo Corporation, Edwards Lifesciences Corporation, W. L. Gore & Associates Inc., Bracco Group, LivaNova PLC, Meril Life Sciences Pvt. Ltd., CryoLife Inc., Braile Biomedica, TTK Healthcare Limited, Direct Flow Medical Inc., JenaValve Technology Inc., Micro Interventional Devices Inc., CardioKinetix Inc., Xeltis AG, Ancora Heart Inc., JOMDD Inc., Valcare Medical, BioStable Science & Engineering Inc., Comed B.V., Transcatheter Technologies GmbH, Navilyst Medical Inc.

North America was the largest region in the structural heart devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the structural heart devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the structural heart devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The structural heart devices market consists of sales of paravalvular leak closure devices, endovascular stents, and percutaneous mitral valve replacement. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Structural Heart Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on structural heart devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for structural heart devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The structural heart devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Heart Valve Devices; Annuloplasty Rings; Occluders; Delivery Systems
  • 2) By Procedure: Replacement Procedures; Repair Procedures
  • 3) By Indication: Atrial Septal Defect; Patent Foramen Ovale; Ventricular Septal Defect; Aortic Valve Stenosis; Other Indications
  • 4) By Age Group: Pediatric; Adults
  • Subsegments:
  • 1) By Heart Valve Devices: Transcatheter Heart Valves; Surgical Heart Valves; Annuloplasty Rings
  • 2) By Annuloplasty Rings: Mitral Annuloplasty Rings; Aortic Annuloplasty Rings
  • 3) By Occluders: Atrial Septal Defect (Asd) Occluders; Patent Foramen Ovale (Pfo) Occluders
  • 4) By Delivery Systems: Balloon Delivery Systems; Catheter-Based Delivery Systems
  • Companies Mentioned: Abbott Laboratories; Medtronic Plc; Boston Scientific Corporation; Terumo Corporation; Edwards Lifesciences Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Structural Heart Devices Market Characteristics

3. Structural Heart Devices Market Trends And Strategies

4. Structural Heart Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Structural Heart Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Structural Heart Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Structural Heart Devices Market Growth Rate Analysis
  • 5.4. Global Structural Heart Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Structural Heart Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Structural Heart Devices Total Addressable Market (TAM)

6. Structural Heart Devices Market Segmentation

  • 6.1. Global Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Heart Valve Devices
  • Annuloplasty Rings
  • Occluders
  • Delivery Systems
  • 6.2. Global Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Replacement Procedures
  • Repair Procedures
  • 6.3. Global Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect
  • Patent Foramen Ovale
  • Ventricular Septal Defect
  • Aortic Valve Stenosis
  • Other Indications
  • 6.4. Global Structural Heart Devices Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Pediatric
  • Adults
  • 6.5. Global Structural Heart Devices Market, Sub-Segmentation Of Heart Valve Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Transcatheter Heart Valves
  • Surgical Heart Valves
  • Annuloplasty Rings
  • 6.6. Global Structural Heart Devices Market, Sub-Segmentation Of Annuloplasty Rings, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mitral Annuloplasty Rings
  • Aortic Annuloplasty Rings
  • 6.7. Global Structural Heart Devices Market, Sub-Segmentation Of Occluders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Atrial Septal Defect (Asd) Occluders
  • Patent Foramen Ovale (Pfo) Occluders
  • 6.8. Global Structural Heart Devices Market, Sub-Segmentation Of Delivery Systems, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Delivery Systems
  • Catheter-Based Delivery Systems

7. Structural Heart Devices Market Regional And Country Analysis

  • 7.1. Global Structural Heart Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Structural Heart Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Structural Heart Devices Market

  • 8.1. Asia-Pacific Structural Heart Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Structural Heart Devices Market

  • 9.1. China Structural Heart Devices Market Overview
  • 9.2. China Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Structural Heart Devices Market

  • 10.1. India Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Structural Heart Devices Market

  • 11.1. Japan Structural Heart Devices Market Overview
  • 11.2. Japan Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Structural Heart Devices Market

  • 12.1. Australia Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Structural Heart Devices Market

  • 13.1. Indonesia Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Structural Heart Devices Market

  • 14.1. South Korea Structural Heart Devices Market Overview
  • 14.2. South Korea Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Structural Heart Devices Market

  • 15.1. Western Europe Structural Heart Devices Market Overview
  • 15.2. Western Europe Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Structural Heart Devices Market

  • 16.1. UK Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Structural Heart Devices Market

  • 17.1. Germany Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Structural Heart Devices Market

  • 18.1. France Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Structural Heart Devices Market

  • 19.1. Italy Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Structural Heart Devices Market

  • 20.1. Spain Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Structural Heart Devices Market

  • 21.1. Eastern Europe Structural Heart Devices Market Overview
  • 21.2. Eastern Europe Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Structural Heart Devices Market

  • 22.1. Russia Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Structural Heart Devices Market

  • 23.1. North America Structural Heart Devices Market Overview
  • 23.2. North America Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Structural Heart Devices Market

  • 24.1. USA Structural Heart Devices Market Overview
  • 24.2. USA Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Structural Heart Devices Market

  • 25.1. Canada Structural Heart Devices Market Overview
  • 25.2. Canada Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Structural Heart Devices Market

  • 26.1. South America Structural Heart Devices Market Overview
  • 26.2. South America Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Structural Heart Devices Market

  • 27.1. Brazil Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Structural Heart Devices Market

  • 28.1. Middle East Structural Heart Devices Market Overview
  • 28.2. Middle East Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Structural Heart Devices Market

  • 29.1. Africa Structural Heart Devices Market Overview
  • 29.2. Africa Structural Heart Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Structural Heart Devices Market, Segmentation By Procedure, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Structural Heart Devices Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Structural Heart Devices Market Competitive Landscape And Company Profiles

  • 30.1. Structural Heart Devices Market Competitive Landscape
  • 30.2. Structural Heart Devices Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Edwards Lifesciences Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Structural Heart Devices Market Other Major And Innovative Companies

  • 31.1. W. L. Gore & Associates Inc.
  • 31.2. Bracco Group
  • 31.3. LivaNova PLC
  • 31.4. Meril Life Sciences Pvt. Ltd.
  • 31.5. CryoLife Inc.
  • 31.6. Braile Biomedica
  • 31.7. TTK Healthcare Limited
  • 31.8. Direct Flow Medical Inc.
  • 31.9. JenaValve Technology Inc.
  • 31.10. Micro Interventional Devices Inc.
  • 31.11. CardioKinetix Inc.
  • 31.12. Xeltis AG
  • 31.13. Ancora Heart Inc.
  • 31.14. JOMDD Inc.
  • 31.15. Valcare Medical

32. Global Structural Heart Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Structural Heart Devices Market

34. Recent Developments In The Structural Heart Devices Market

35. Structural Heart Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Structural Heart Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Structural Heart Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Structural Heart Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer